These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6685633)
21. Quality control of estrogen and progesterone receptor assays. Chua D; Aw SE; Chan SH; Oon CJ Ann Acad Med Singap; 1986 Oct; 15(4):492-7. PubMed ID: 3566169 [TBL] [Abstract][Full Text] [Related]
22. Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols. Experience of the E.O.R.T.C. Receptor Group. Blankenstein MA Breast Cancer Res Treat; 1990 Dec; 17(2):91-8. PubMed ID: 2096997 [TBL] [Abstract][Full Text] [Related]
23. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer. Norgren A; Borg A; Fernö M; Johansson U; Lindahl B; Tsiobanelis K Anticancer Res; 1982; 2(5):315-20. PubMed ID: 6187272 [TBL] [Abstract][Full Text] [Related]
24. Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer. Mobbs BG; Johnson IE J Steroid Biochem; 1987 Dec; 28(6):653-62. PubMed ID: 3320574 [TBL] [Abstract][Full Text] [Related]
25. Estrogen and progesterone receptor content in breast tumor cytosols calculated with a pocket calculator. Tabachnick J Clin Chem; 1985 Jul; 31(7):1251-2. PubMed ID: 4006212 [No Abstract] [Full Text] [Related]
26. Variation of estrogen and progesterone receptor status in breast cancer. Alanko A Ann Clin Res; 1985; 17(1):10-4. PubMed ID: 4015025 [TBL] [Abstract][Full Text] [Related]
27. Protein method influences on calculation of tissue receptor concentration. Howanitz PJ; Howanitz JH; Skrodzki CA; Woloszyn T Am J Clin Pathol; 1986 Jan; 85(1):37-42. PubMed ID: 3940419 [TBL] [Abstract][Full Text] [Related]
28. Quality control of receptor analyses of breast cancer tissue in Denmark. Thorpe SM; Poulsen HS; Pedersen KO; Rose C Acta Oncol; 1988; 27(6A):621-5. PubMed ID: 2464357 [TBL] [Abstract][Full Text] [Related]
29. Relationship between radioligand binding assay, immunoenzyme assay and immunohistochemical assay for estrogen receptors in human breast cancer and association with tumor differentiation. Andersen J; Bentzen SM; Poulsen HS Eur J Cancer Clin Oncol; 1988 Mar; 24(3):377-84. PubMed ID: 3289941 [TBL] [Abstract][Full Text] [Related]
30. Association of plasminogen activator activity and steroid receptors in human breast cancer. Thorsen T Eur J Cancer Clin Oncol; 1982 Feb; 18(2):129-32. PubMed ID: 7201390 [TBL] [Abstract][Full Text] [Related]
31. Sources of improvement in between laboratory variation in estrogen and progestin receptor measurement using tissue samples during the Australian Quality Assurance Programme. Borjesson BW; Cauchi MN; Compton PJ; Elder PA; Foo TM; Gramacho C; Hähnel R; Harrison LC; Holdaway IM; Horsfall DJ Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1087-93. PubMed ID: 2668010 [TBL] [Abstract][Full Text] [Related]
32. Intratumoral variation of estrogen and progesterone receptors in breast cancer: relationship with histopathological characteristics of the tumor. Jarque F; Lluch A; Vera FJ; Pascual A; Vizcarra E; Alberola V; García-Conde J Oncology; 1990; 47(1):9-13. PubMed ID: 2300392 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method. Thorpe SM Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474 [TBL] [Abstract][Full Text] [Related]
34. Interlaboratory variability in the determination of estrogen receptor and progesterone receptor content in human breast tumors: quality control in Switzerland. Zava DT Recent Results Cancer Res; 1984; 91():122-8. PubMed ID: 6539493 [No Abstract] [Full Text] [Related]
35. Steroid hormone receptors and sex chromatin frequency in breast cancer. Smethurst M; Bishun NP; Fernandez D; Allen J; Burn JI; Alaghband-Zadeh J; Williams DC J Endocrinol Invest; 1981; 4(4):455-7. PubMed ID: 7334186 [TBL] [Abstract][Full Text] [Related]
36. Quality control of clinical steroid receptor assays in Sweden. Sällström JF; Björkqvist K Recent Results Cancer Res; 1984; 91():119-21. PubMed ID: 6729207 [No Abstract] [Full Text] [Related]
37. Reliability of steroid hormone receptor assays: an international study. Jordan VC; Zava DT; Eppenburger U; Kiser A; Sebek S; Dowdle E; Krozowski Z; Bennett RC; Funder J; Holdaway IM; Wittliff JL Eur J Cancer Clin Oncol; 1983 Mar; 19(3):357-63. PubMed ID: 6683173 [TBL] [Abstract][Full Text] [Related]
38. [Standardization of receptor diagnosis in breast cancer]. Hickler W; Scheiermann N; Riffelmann HD; Kreuzfelder E Dtsch Med Wochenschr; 1986 Dec; 111(50):1931-3. PubMed ID: 3780470 [No Abstract] [Full Text] [Related]
39. Immunoglobulin G (IgG) levels in breast tumor cytosols. Winsten S; Tabachnick J; Young I Am J Clin Pathol; 1985 Mar; 83(3):364-6. PubMed ID: 3976571 [TBL] [Abstract][Full Text] [Related]
40. Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer. Sumida C; Magdelenat H; Pasqualini JR Breast Cancer Res Treat; 1985; 5(2):165-9. PubMed ID: 4016282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]